rss
Postgrad Med J 2003;79:189-194 doi:10.1136/pmj.79.930.189
  • Review

Modern treatment of acromegaly

  1. Z Merza
  1. Correspondence to:
 Dr Zayd Merza, Endocrine and Diabetes Centre, Northern General Hospital, Sheffield S5 7AU, UK; 
 zmerza{at}aol.com
  • Received 27 November 2002
  • Accepted 21 December 2002

Abstract

Acromegaly is an endocrine disorder characterised by increased morbidity and mortality. It is usually caused by a growth hormone secreting pituitary adenoma and is manifested by a variety of clinical features. Surgery is usually the treatment of choice, however over the last few years, several new methods of treatment have been developed. A recent consensus on the targets for treatment has led to multiple studies being conducted to assess the efficacy of the currently available options. This review examines the evidence for and against these treatments.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.